Cargando…
A pan-cancer analysis of MYC-PVT1 reveals CNV-unmediated deregulation and poor prognosis in renal carcinoma
The PVT1 lncRNA has recently been involved in tumorigenesis by affecting the protein stability of the MYC proto-oncogene. Both MYC and PVT1 reside in a well-known cancer-risk locus and enhanced levels of their products have been reported in different human cancers. Nonetheless, the extension and rel...
Autores principales: | Posa, Ioana, Carvalho, Silvia, Tavares, Joana, Grosso, Ana Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216921/ https://www.ncbi.nlm.nih.gov/pubmed/27366943 http://dx.doi.org/10.18632/oncotarget.9487 |
Ejemplares similares
-
The PVT1-MYC duet in cancer
por: Tseng, Yuen-Yi, et al.
Publicado: (2015) -
A Systematic Pan-Cancer Analysis of Genetic Heterogeneity Reveals Associations with Epigenetic Modifiers
por: de Matos, Mafalda Ramos, et al.
Publicado: (2019) -
MYC Deregulation in Primary Human Cancers
por: Kalkat, Manpreet, et al.
Publicado: (2017) -
Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers
por: Takahashi, Y, et al.
Publicado: (2014) -
MYC Deregulation in Gastric Cancer and Its Clinicopathological Implications
por: de Souza, Carolina Rosal Teixeira, et al.
Publicado: (2013)